Insider Transactions in Q1 2023 at Molina Healthcare, Inc. (MOH)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
Daniel Cooperman Director |
SELL
Open market or private sale
|
Direct |
5,000
-50.28%
|
$1,380,000
$276.77 P/Share
|
|
Mar 03
2023
|
Daniel Cooperman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+33.46%
|
$165,000
$33.02 P/Share
|
|
Mar 01
2023
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,699
-8.01%
|
$3,466,827
$273.8 P/Share
|
|
Mar 01
2023
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,967
+12.32%
|
$6,542,991
$273.8 P/Share
|
|
Mar 01
2023
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,708
-12.81%
|
$3,742,284
$273.44 P/Share
|
|
Mar 01
2023
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,324
+20.8%
|
$8,278,452
$273.08 P/Share
|
|
Mar 01
2023
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,382
-7.91%
|
$377,286
$273.8 P/Share
|
|
Mar 01
2023
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,382
+14.91%
|
$923,286
$273.8 P/Share
|
|
Mar 01
2023
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
78,323
-10.98%
|
$21,382,179
$273.8 P/Share
|
|
Mar 01
2023
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
157,282
+16.76%
|
$42,937,986
$273.44 P/Share
|
|
Mar 01
2023
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,153
-8.22%
|
$2,498,769
$273.8 P/Share
|
|
Mar 01
2023
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,697
+17.63%
|
$6,742,281
$273.8 P/Share
|
|
Mar 01
2023
|
Marc Russo EVP, Health Plans |
SELL
Payment of exercise price or tax liability
|
Direct |
20,780
-19.74%
|
$5,672,940
$273.8 P/Share
|
|
Mar 01
2023
|
Marc Russo EVP, Health Plans |
BUY
Grant, award, or other acquisition
|
Direct |
47,062
+30.36%
|
$12,847,926
$273.8 P/Share
|
|
Jan 01
2023
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+3.7%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+0.8%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+0.99%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+2.89%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+3.27%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+10.6%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+1.06%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+1.35%
|
$55,110
$330.22 P/Share
|